Unitary Patent: Stop talking, start planning

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Unitary Patent: Stop talking, start planning

Today is a turning-point for patents in Europe. The Court of Justice of the EU has ruled on Spain’s challenge to the Unitary Patent Regulations, and we need to start looking forward to how the new system will work in practice

CJEU judges

As we reported this morning, the Grand Panel of the Court (pictured right) dismissed every aspect of Spain’s dual challenge, the second time the country has queried the Unitary Patent plan. That must remove any remaining uncertainties over the legal basis of the EU scheme, even if it doesn’t (yet) persuade the Spanish government to sign up.

The opponents of the proposed system, led by the Spanish government, had some strong and sincerely held arguments against it. The Court has firmly, clearly and finally rejected these, as the Advocate General did last year.

No doubt some critics will remain unpersuaded by its judgments, will continue to criticise the proposed system and may even seek further reviews at the European Court of Human Rights.

But surely now is the time for everyone to take a deep breath and say: the CJEU has clearly spoken, much of the work is underway and patent applicants (and third parties) need certainty. Whatever your personal views about the merits of what is proposed, it is time to put them aside and try to make the system work in practice.

Above all that means: How much will it cost? When will it come into effect? And should I use the system for some or all of my patents?

EU flag

We now need to see some more activity from governments and the EPO to clarify renewal, opt-out and court fees, the final rules of procedure and judicial appointments. The recent proposals on fees, while not as low as most users would like, are at least a starting point, and we understand that there may be further announcements on the other fees within the next week.

I know from speaking to in-house counsel that news on costs cannot come soon enough: many are already working on budgets that could be affected by the Unitary Patent (for example, the opt-out fees) and need to make spending decisions.

Patent practitioners in Europe also have a duty to their clients, and to the public at large, to make the system work as efficiently and fairly as possible. That includes building expertise, engaging in consultations and promoting understanding.

We’ve had several years or debate about the advantages and shortfalls of the Unitary Patent and UPC and what is proposed certainly does not please everybody. But the time for arguing is now over, and the time for planning how to make it work in practice work must begin in earnest.

more from across site and SHARED ros bottom lb

More from across our site

Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Gift this article